[1] Lu L, Zeng J, Wen Z, et al. Transcatheter arterial chemoembolisation followed by three-dimensional conformal radiotherapy versus transcatheter arterial chemoembolisation alone for primary hepatocellular carcinoma in adults. Cochrane Database Syst Rev, 2019, 2(2): 12244. [2] Kimura T, Fujiwara T, Kameoka T, et al. The current role of stereotactic body radiation therapy (SBRT) in hepatocellular carcinoma (HCC). Cancers (Basel), 2022, 14(18):4383. [3] Wei X, Jiang Y, Zhang X, et al. Neoadjuvant three-dimensional conformal radiotherapy for resectable hepatocellular carcinoma with portal vein tumor thrombus: A randomized, open-label, multicenter controlled study. J Clin Oncol, 2019, 37(24): 2141-2151. [4] Zhang H, Yang A, Zhang J. Efficacy of transcatheter arterial chemoembolization combined with125I seed implantation and three-dimensional conformal radiotherapy in advanced primary hepatocellular carcinoma. J BUON, 2020, 25(2): 952-958. [5] Prayongrat A, Srimaneekarn N, Sriswasdi S, et al. Assessment of the confidence interval in the multivariable normal tissue complication probability model for predicting radiation-induced liver disease in primary liver cancer. J Radiat Res, 2021, 62(3): 483-493. [6] 张丹, 孙静, 王佳, 等. 原发性肝细胞癌患者立体定向放射治疗所致的放射性肝损伤影响因素分析. 中华肝脏病杂志, 2021, 29(6):575-579. [7] 国家卫生健康委办公厅. 原发性肝癌诊疗指南(2022年版). 临床肝胆病杂志, 2022, 38(2): 288-303. [8] Vogel A, Saborowski A. Current strategies for the treatment of intermediate and advanced hepatocellular carcinoma. Cancer Treat Rev, 2020, 82:101946. [9] Yu X, Yang R, He Z, et al. Construction and validation of a nomogram for hepatocellular carcinoma patients treated by traditional Chinese medicine based on inflammation, nutrition, and blood lipid indicators. J Cancer Res Clin Oncol, 2023,149(11):8969-8979. [10] 梁长华, 毛华杰, 梁盼, 等. 原发性肝癌320排容积CT灌注参数值与肿瘤体积及肝功能Child-Pugh分级的相关性. 新乡医学院学报, 2018, 35(1): 65-68. [11] Shi S, Yu XJ. Time to think: Selecting patients who may benefit from synchronous resection of primary pancreatic cancer and liver metastases. World J Gastroenterol, 2018, 24(33): 3677-3680. [12] Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin, 2018, 68(6):394-424. [13] 占小波, 应学清, 张竝. 腹腔镜微波消融术联合三维适形放疗治疗肝癌转移患者的临床疗效观察. 广东医学, 2019, 40(19): 2754-2758. [14] Haefner MF, Lang K, Verma V, et al. Intensity-modulated versus 3-dimensional conformal radiotherapy in the definitive treatment of esophageal cancer: comparison of outcomes and acute toxicity. Radiat Oncol, 2017, 12(1):131. [15] 顾凯, 吴晓晨, 朱逸明. 单次大剂量肝区放射照射治疗PLC肝区疼痛患者效果研究. 实用肝脏病杂志, 2023, 26(2): 270-273. [16] Ibrahim AM, Nady S, Shafaa MW, et al. Radiation and chemotherapy variable response induced by tumor cell hypoxia: impact of radiation dose, anticancer drug, and type of cancer. Radiat Environ Biophys, 2022, 61(2): 263-277. [17] Aoki S, Yamashita H, Abe O, et al. Stereotactic body radiotherapy (SBRT) for oligo-metastatic liver metastases from breast cancer, as an effective and safe alternative to surgery: a review. Transl Cancer Res, 2020, 9(8): 5087-5095. |